The Metabolic Syndrome and Type 2 Diabetes: Epidemiological Figures and Country Specificities

Over the last 20 years, the prevalence of the metabolic syndrome has steadily increased in all populations worldwide, changing slowly the phenotype of the human race and potentially our concept of physiological normality. Our affluent phenotype reflects progressive adaptation to the external environment, which in turn changes the standards of the metabolic variables such as body weight, blood pressure, lipid values and glucose homeostasis. The human survivors of the difficult times of the hunter-gatherer period have probably benefited from genes which have allowed for more efficient food utilization, fat deposition and weight gain, a concept referred to as the ‘thrifty gene’ hypothesis. This genetic background has now become detrimental in our society of high energy consumption, little physical activity and lifestyles that favour stress and anxiety. These genetic and environmental interactions explain the explosion in the prevalence of the metabolic syndrome and diabetes. If future estimates for the number of patients with diabetes and impaired glucose tolerance are valid, this will have a major and adverse impact on the number of stroke patients globally.

[1]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[2]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[3]  F. Azizi,et al.  Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. , 2003, Diabetes research and clinical practice.

[4]  G. Duncan,et al.  Prevalence and trends of a metabolic syndrome phenotype among u.s. Adolescents, 1999-2000. , 2004, Diabetes care.

[5]  G. Reaven Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[6]  B. Balkau,et al.  The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. , 2003, Diabetes & metabolism.

[7]  J. Shaw,et al.  The metabolic syndrome: prevalence in worldwide populations. , 2004, Endocrinology and metabolism clinics of North America.

[8]  I. Holme,et al.  Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study. , 1995, Stroke.

[9]  E. Barrett-Connor,et al.  Diabetes mellitus: an independent risk factor for stroke? , 1988, American journal of epidemiology.

[10]  Anthony Gamst,et al.  Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey , 2004, Circulation.

[11]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[12]  Lisa Kiblinger,et al.  Diabetes Risk/ , 2007, The Diabetes educator.

[13]  Ali H Mokdad,et al.  Increasing prevalence of the metabolic syndrome among u.s. Adults. , 2004, Diabetes care.

[14]  E. Gale The changing phenotype of the human species (affluent variety) , 2004, Diabetologia.

[15]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[16]  E. Shahar,et al.  Trends in Diabetes Prevalence Among Stroke Patients and the Effect of Diabetes on Stroke Survival: the Minnesota Heart Survey , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[17]  K. Borch-Johnsen,et al.  The metabolic syndrome—is one global definition possible? , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[18]  A. Green,et al.  Rising prevalence of diabetes: evidence from a Danish pharmacoepidemiological database. , 2003, The Lancet.

[19]  M. Rodríguez-Moran,et al.  Metabolic syndrome among children and adolescents aged 10-18 years. , 2004, Diabetes care.

[20]  K. Asplund,et al.  Diabetes as a risk factor for stroke. A population perspective , 1995, Diabetologia.

[21]  J. Neel Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[22]  D. Ziegler,et al.  Stroke in patients with diabetes mellitus , 2004, Diabetes/metabolism research and reviews.

[23]  J. Diamond,et al.  The double puzzle of diabetes , 2003, Nature.